Sarepta Therapeutics (SRPT) Return on Invested Capital (2017 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Return on Invested Capital of 0.03% for Q1 2026, down 2.0% year-over-year from 0.03% in Q1 2025, and up 84.67% quarter-over-quarter from 0.2% in Q4 2025.
Sarepta Therapeutics (SRPT) Return on Invested Capital (2017 - 2026) Analysis & Trends
Sarepta Therapeutics' Return on Invested Capital history runs 6 years deep, the most recent figure standing at 0.03% for Q1 2026.
- In Q1 2026, Return on Invested Capital fell 2.0% year-over-year to 0.03%; the TTM figure through Mar 2026 stood at 0.03% (down 2.0% YoY), while the FY2017 annual figure was 0.36%, changed N/A from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.03%, up from 0.2% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.01% in Q4 2024, with the low at 0.2% in Q4 2025.
- The 3-year median for Return on Invested Capital is 0.0% (2024), against an average of 0.03%.
- Peak annual rise in Return on Invested Capital reached 0 bps in 2025, while the deepest fall reached 20 bps in 2025.
- Sarepta Therapeutics' Return on Invested Capital stood at 0.01% in 2024, then slumped by 3531 bps to 0.2% in 2025, then jumped by 85 bps to 0.03% in 2026.
- Business Quant data shows SRPT's Return on Invested Capital at 0.03% in Q1 2026, 0.2% in Q4 2025, and 0.02% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.05% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.35% |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | -0.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.04% |
| Mar 31, 2026 | -0.03% |
| Dec 31, 2025 | -0.20% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Mar 31, 2019 | -0.35% |
| Dec 31, 2018 | -0.21% |
| Sep 30, 2018 | -0.11% |
| Jun 30, 2018 | -0.08% |
| Mar 31, 2018 | -0.06% |
| Dec 31, 2017 | -0.05% |
| Sep 30, 2017 | -0.06% |
| Jun 30, 2017 | -0.06% |
| Mar 31, 2017 | -0.06% |